Rankings
▼
Calendar
BDX Q3 2021 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena
BDX
Becton, Dickinson and Company
$59B
Q3 2021 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$4.6B
+19.5% YoY
Gross Profit
$2.0B
42.5% margin
Operating Income
$492M
10.7% margin
Net Income
$525M
11.4% margin
EPS (Diluted)
$1.72
QoQ Revenue Growth
-6.1%
Cash Flow
Operating Cash Flow
$975M
Free Cash Flow
$708M
Stock-Based Comp.
$51M
Balance Sheet
Total Assets
$54.3B
Total Liabilities
$30.2B
Stockholders' Equity
$24.1B
Cash & Equivalents
$3.2B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.6B
$3.9B
+19.5%
Gross Profit
$2.0B
$1.7B
+18.0%
Operating Income
$492M
$358M
+37.4%
Net Income
$525M
$286M
+83.6%
Revenue Segments
Medical
$2.4B
49%
Life Sciences
$1.4B
29%
Interventional
$1.1B
22%
Geographic Segments
UNITED STATES
$2.6B
53%
Non-US
$2.3B
47%
← FY 2021
All Quarters
Q4 2021 →